Cyclacel pharmaceuticals to release first quarter 2024 financial results

Berkeley heights, n.j., may 08, 2024 (globe newswire) -- cyclacel pharmaceuticals, inc. (nasdaq: cycc, nasdaq: cyccp; "cyclacel" or the "company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce first quarter 2024 financial results on tuesday, may 14, 2024. the company will host a conference call and live webcast at 4:30 p.m. eastern daylight time on the same day.
CYCC Ratings Summary
CYCC Quant Ranking